Evidence-based psychopharmacology 3. Assessing evidence of harm: what are the teratogenic effects of lithium carbonate?
Critical appraisal techniques are not only useful in evaluating evidence of therapeutic trials. In this final article of the series of evidence-based psychopharmacology, the evidence about the teratogenic effects of lithium carbonate is considered. This exercise highlights the importance of assessing the evidence oneself and not relying on the interpretation others put on it.
Warner
J P
JP
Imperial College of Science, Technology and Medicine, St Charles Hospital, London, UK. j.warner@ic.ac.uk
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D016651:Lithium Carbonate / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D012307:Risk Factors
D018692:Antimanic Agents; D016651:Lithium Carbonate